SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is seeing intense community speculation and high volatility as investors anticipate the imminent 80th event milestone for the REGAL Phase 3 trial. Discussion is heavily focused on the stock's elevated short interest and rising borrow rates, with bulls positioning for a potential squeeze while highlighting the company's recent commentary on its transition toward late-stage commercialization.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending following the announcement of a joint research agreement with Honda to advance solid-state battery development and manufacturing processes. Community sentiment is currently split between optimism regarding this high-profile validation of the company's technology and skepticism over the lack of near-term commercial revenue.

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is trending following a record-breaking earnings report that highlighted significant revenue growth, a successful partnership with Midjourney, and the company's first positive operating cash flow. The community is actively debating the company's long-term potential as it transitions from a hardware-focused business to a semiconductor-driven AI platform.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is seeing intense trading volume and volatility as the market reacts to shifting geopolitical tensions between the U.S. and Iran alongside broader uncertainty regarding Federal Reserve rate policy. Community discussions remain polarized, with many traders actively debating the sustainability of the ongoing AI-driven rally while utilizing the ETF to capitalize on rapid intraday price swings.

Accenture is a global professional services company that helps the world’s businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services, creating tangible value at speed and scale. The firm combines technology and leadership in cloud, data and AI with industry experience, functional expertise and global delivery capability. Its services include Strategy & Consulting, Technology, Operations, Industry X, and Song. It operates through the following geographical segments: North America, EMEA, and Growth Markets. The company was founded in 1989 and is headquartered in Dublin, Ireland.

Accenture plc - Ordinary Shares - Class A

Accenture is currently under intense pressure as investors express concerns that generative AI tools could disrupt the firm's traditional billable-hour consulting model. Community sentiment is notably bearish, with many questioning the company's long-term relevance and leadership strategy following a disappointing revenue outlook and significant stock price depreciation.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors weigh recent financial disclosures, including a debt buyback and updated profitability timelines, against ongoing anticipation of EMA regulatory decisions. Community discourse remains divided between strong conviction in the companys long-term commercial potential and frustration over executive turnover and limited transparency from leadership.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

iShares Silver Trust (SLV) is facing intense selling pressure as investors weigh cooling inflation expectations against ongoing geopolitical tensions in the Middle East and concerns over high interest rates. While some in the community argue that long-term industrial demand from AI infrastructure and solar manufacturing makes this a prime dip-buying opportunity, others remain skeptical, warning of further downside as the sector struggles to maintain its safe-haven status.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Two Interactive is trending as investors rally around the confirmed November launch of Grand Theft Auto VI and imminent preorder opportunities starting June 25. The community is actively debating the stock's long-term valuation as a recurring revenue machine, with bulls pointing to the game's record-shattering sales potential and strong recurring revenue potential as key drivers for future upside.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

The VanEck Gold Miners ETF (GDX) is trending as investors weigh conflicting macroeconomic signals, with the community actively debating whether the sector is experiencing a healthy consolidation or a failed breakdown amidst shifting expectations for Fed policy. Discussions remain focused on the impact of persistent inflation, the geopolitical landscape, and technical levels as traders attempt to gauge the next leg for gold miners.

Centrus Energy Corp. engages in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment includes various components of nuclear fuel to utilities from its global network of suppliers. The Technical Solutions segment offers advanced engineering, design, and manufacturing services to government and private sector customers, and is deploying advanced nuclear fuel production capabilities to power existing, and next-generation reactors around the world. The company was founded in October 1992 and is headquartered in Bethesda, MD.

Centrus Energy Corp - Ordinary Shares - Class A

Centrus Energy Corp 

Centrus Energy is trending due to a major strategic partnership with Palantir Technologies to optimize their uranium enrichment operations, sparking optimism for operational efficiency and long-term cost reduction. The community is heavily focused on the company's critical role in the U.S. domestic nuclear fuel supply chain, viewing the stock as a key bottleneck player in the broader energy transition as data center power demands surge.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CarMax Well Positioned For Growth, Says Wedbush: Retail Sentiment Improves

Equity

Wedbush said while tariffs could raise parts costs, the overall impact on reconditioning expenses is limited, and CarMax is largely shielded from supply disruptions as it sources most inventory independently.


CarMax Shares Dive On Weak Q4 Print, But Retail Bets Trump Tariffs Will Rev Up Used Car Demand  

Stock fell 17%, its worst single-day decline since September 2022.

Helen Of Troy Stock Inches Up After Q2 Earnings Beat Estimates, Retail Sentiment Remains Lukewarm

The maker of household and beauty products such as Vicks, Braun, and Revlon also reaffirmed its full-year outlook for net sales, adjusted EPS, and adjusted EBITDA



Pre-Market Movers: Retail's Pulse On Faraday Future, Nvidia and VBI Vaccines

EV-maker Faraday Future had some pleasing news for investors, as shares rocketed before the bell. Nvidia, meanwhile, rode on the cheer surrounding a rival’s strong earnings. But for VBI Vaccines, it has come down to a fight for survival.


VBI Vaccines, Inc. is a biopharmaceutical company, which engages in the development of infectious disease and immuno-oncology vaccines. The firm focuses on the prevention and treatment of hepatitis B through its product pipeline, Sci-B-Vac and VBI-2601. It also develops an enveloped virus-like particle (eVLP) platform technology, which allows the development of eVLP vaccines that closely mimic the target virus to elicit a potent immune response. The company was founded on April 9, 1965 and is headquartered in Cambridge, MA.

VBI Vaccines Inc.

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.0005
Prev Close	$0.0005
Open	$0.0005
Dividend Yield	N/A
50-Day Moving Average	$0.0005
Beta	-21.45
Avg. Volume	51,457.38
PE Ratio	0.00

52-Week High	$0.0505
52-Week Low	$0.00
Market Capitalization	$14,341.00
EPS (Annual)	N/A
Price to Book	-0.00
Revenue Per Employee	N/A

VBIVVBI Vaccines Inc.

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VBIV News